Navigation Links
Anthrax drug doxycycline could stunt fetal growth

The government warned doctors that doxycycline -- an antibiotic being prescribed to people who may have been exposed to anthrax -- can stunt fetal growth when taken by pregnant women. Instead, the Centers for Disease Control and Prevention urged doctors to prescribe Cipro to pregnant women. The recommendation comes as health officials worry that Cipro is being overprescribed in the general population, possibly causing common bacteria to become resistant to the drug. //

The CDC has asked doctors to first consider doxycycline, which works equally well against strains of anthrax detected in recent weeks in the United States. But doxycycline is part of a class of drugs that can endanger fetuses, including staining primary teeth, weakening tooth enamel and stunting bone growth, the CDC warned.

No formal studies have been conducted on how Cipro affects pregnancy, but the CDC said the drug is unlikely to pose a substantial risk. Doctors can also consider amoxicillin, a relative of penicillin.


Page: 1

Related medicine news :

1. Drugs For Anthrax May Interfere With Oral Contraceptives
2. Cipro Has Cheaper Cousins to Treat Anthrax
3. Panacea Biotech To Market Anthrax Vaccine
4. Anthrax vaccine produced
5. Prototype Detector detects Anthrax Quickly
6. Effective And Economical Agent For Anthrax
7. Anthrax hammers immune system
8. Identifying Predictors Of Anthrax
9. New Inhalation Anthrax Vaccine
10. Anthrax Scare In Tamil Nadu State of India
11. Anthrax Scare In Tamil Nadu State of India
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates ... a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they ... Society of North America (RSNA) 2015 annual meeting through December 3 in Chicago, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... that the company will present at the LD Micro Main ... Luxe Sunset Boulevard Hotel in Los Angeles, CA. ... will present on Thursday, December 3, at 9:00 am Pacific ... register at least 10 minutes prior to the start of ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology: